Cardiovascular

Category

Lost Time can Mean Lost Lives: Researchers and Patients Thankful as Lab Research Resumes

For some individuals with congestive heart failure, the COVID-19 shutdowns couldn’t have come at a worse time as many research centers had to temporarily halt studies. This put some patients at great risk. In one case, a patient named Brendle Miller found an active...

Black Forest Researchers ‘Get busy’ with €30M in New Collaborative Research Center (CRC) Funding

The German Research Foundation (DFG) gave the green light for €30M in new research projects for the Institute for Experimental Cardiovascular Medicine (IEKM), University of Heart Center & other translational-minded research groups anchored at the University of...

AHA-Backed Study Reveals Ongoing Lack of Minority & Female Participation in Cardiometabolic Clinical Trials

Unfortunately, yet another report reveals the dearth of women and minorities, especially African Americans’ representation in clinical trials in the critically important cardiovascular and metabolic therapeutic domain. The results of a recent study published in the...

Duke Clinical Research Institute Collaborates with BI & Eli Lilly to Lead EMPACT-MI Pragmatic Clinical Trial

Duke Clinical Research Institute (DCRI) inked a clinical trials collaborative deal with the world’s largest privately held drug company—Boehringer Ingelheim—and publicly traded Eli Lilly (NYSE:LLY) to launch the EMPACT-MI (EMPAgliflozin for the prevention of Chronic...

The Site-less Trial Commences with the Heartline Study Powered by Apple, Evidation Health & Janssen (J&J)

Johnson & Johnson’s Janssen Pharmaceutical unit inked a partnership with Apple to leverage the iPhone and FDA-complaint apps for a new study—the Heartline Study—designed to assess if apps on the iPhone and features on the Apple Watch can improve health outcomes...

Pin It on Pinterest